title: Editorial comment from Dr Mori to recent topics related to nephrogenic systemic fibrosis associated with gadolinium-based contrast agents.
authors.forename: Harushi
authors.initials: H
authors.lastname: Mori
mesh_terms: D003287:Contrast Media / Q000009:adverse effects*; D005682:Gadolinium / Q000009:adverse effects*; D006801:Humans; D054989:Nephrogenic Fibrosing Dermopathy / Q000517:prevention & control*; D051437:Renal Insufficiency / Q000150:complications*
chemical_list: D003287:Contrast Media; D005682:Gadolinium